Back to publication

Effect of lateral versus supine positioning on hypoxaemia in sedated adults: multicentre randomised controlled trial

Assessed by RV013 · Clinical Chair in Health Services Research

Assessed on 16 Nov 2025

OverallReviewer's overall integrity assessment, derived from all research questions Some concerns

DOI 10.1136/bmj-2025-084539 (opens in new tab)

Resource ripekg:research-integrity-assessment/RIPEA535CCB973D036881

5 Research Questions · 152 Evidence Items

Q1.1 — Does the study have an associated retraction?

Automated Assessment:Assessment produced by the automated systemNo
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsNo

Rationale: No notices on journal webpage.

Q1.2 — Does the study have an associated expression of concern or other relevant post-publication notice?

Automated Assessment:Assessment produced by the automated systemNo
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsNo

Rationale: No notices on journal webpage.

Q1.3 — Do other studies by the research team highlight causes for concern?

Automated Assessment:Assessment produced by the automated systemYes
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsUnclear

Rationale: Authors need further investigation for institutions.

Supporting Evidence (150)

Retraction NoticeSource: Retraction Watch database

MicroRNA-145-5p Inhibits Gastric Cancer Invasiveness through Targeting N-Cadherin and ZEB2 to Suppress Epithelial-Mesenchymal Transition

10.2147/ott.s440060 (opens in new tab)
Journal: OncoTargets and TherapyPublisher: Taylor and Francis - Dove PressDate: 15 Sept 2023

RetractionWatch ID:Record identifier in the Retraction Watch database 47576

Rationale: Concerns/Issues About Data;Unreliable Results and/or Conclusions

About Author: Jun Zhang

Retraction NoticeSource: Retraction Watch database

MicroRNA-138 modulates metastasis and EMT in breast cancer cells by targeting vimentin

10.1016/j.biopha.2023.115372 (opens in new tab)
Journal: Biomedicine & PharmacotherapyPublisher: ElsevierDate: 11 Oct 2023

RetractionWatch ID:Record identifier in the Retraction Watch database 47966

Rationale: Concerns/Issues About Image;Falsification/Fabrication of Image;Investigation by Company/Institution;Investigation by Journal/Publisher;Misconduct - Official Investigation(s) and/or Finding(s);Misconduct by Author;Objections by Third Party;Original Data and/or Images not Provided and/or not Available

About Author: Jun Zhang

Retraction NoticeSource: Retraction Watch database

Sports Injury Identification Method Based on Machine Learning Model

10.1155/2023/9790257 (opens in new tab)
Journal: Computational Intelligence and NeurosciencePublisher: HindawiDate: 2 Aug 2023

RetractionWatch ID:Record identifier in the Retraction Watch database 48264

Rationale: Concerns/Issues About Data;Concerns/Issues about Human Subject Welfare;Concerns/Issues about Referencing/Attributions;Concerns/Issues with Peer Review;Investigation by Journal/Publisher;Investigation by Third Party;Lack of IRB/IACUC Approval and/or Compliance;Unreliable Results and/or Conclusions

About Author: Jun Zhang

Q2.2 — Are there concerns relating to the timing or absence of study registration?

Automated Assessment:Assessment produced by the automated systemNo
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsNo

Rationale: Prospective registration.

Supporting Evidence (2)

Clinical Trial RegistrationSource: Clinical trial registry (e.g. ClinicalTrials.gov, ISRCTN)

Registration ID: NCT06459167

Registry: ClinicalTrials.gov

Registry Link: https://clinicaltrials.gov/study/NCT06459167 (opens in new tab)

Registration Date: 10-06-2024

Prospective:Whether the trial was registered before participant recruitment began Yes

Assessment Rationale:How INSPECT-AI determined the prospective registration status by comparing dates Comparison performed at month level. Registration: 2024-06, LLM Recruitment Start: 2024-07. Deemed prospective at month level.

Study Design EvidenceDates and timelines extracted by INSPECT-AI from the publication text

Recruitment Start: 07-2024

Recruitment Start Rationale:INSPECT-AI's reasoning for how it identified the recruitment start date The study was conducted 'from July to November 2024'; used start of conducted range as recruitment_start per rule 5; no specific FPI elsewhere.

Recruitment End: N/A

Recruitment End Rationale:INSPECT-AI's reasoning for how it identified the recruitment end date No direct LPI; range end is not used for recruitment_finish.

Study End: 11-2024

Study End Rationale:INSPECT-AI's reasoning for how it identified the study end date The study was conducted 'from July to November 2024'; used end of conducted range as study_end_date per rule 5; no specific completion date.

Overall — What is the overall integrity assessment of the study?

Automated Assessment:Assessment produced by the automated systemN/A
Human Assessment:Assessment by a domain expert reviewer, informed by AI resultsSome concerns

Rationale: Further work needed on authors.